MedTrace Logo

Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples

NCT00629577 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-02-01

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial is studying gene expression profiling of cervical cancer progression in biopsies and tissue samples from patients with cervical lesions.

Conditions

Interventions

GENETIC

microarray analysis

OTHER

flow cytometry

PROCEDURE

biopsy

PROCEDURE

colposcopy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • British Columbia Cancer Agency

    lead OTHER

Principal Investigators

  • Thomas G Ehlen, M.D. · BC Cancer Agency, Vancouver General Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2010-06-30
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00629577 on ClinicalTrials.gov